| Pharmaceutical Information |
| Drug Name |
Olsalazine |
| Drug ID |
BADD_D01607 |
| Description |
Olsalazine is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease and Ulcerative Colitis. Olsalazine is a derivative of salicylic acid. Inactive by itself (it is a prodrug), it is converted by the bacteria in the colon to mesalamine. Mesalamine works as an anti-inflammatory agent in treating inflammatory diseases of the intestines. |
| Indications and Usage |
For the treatment of Inflammatory Bowel Disease and Ulcerative Colitis. |
| Marketing Status |
Prescription |
| ATC Code |
A07EC03 |
| DrugBank ID |
DB01250
|
| KEGG ID |
D08295
|
| MeSH ID |
C032587
|
| PubChem ID |
22419
|
| TTD Drug ID |
D00KRE
|
| NDC Product Code |
Not Available |
| Synonyms |
olsalazine | azodisalicylate | Dipentum | Rasal | olsalazine sodium | disodium 5,5'-azodisalicylate | sodium diazosalicylate | olsalazine, disodium salt | azodisal sodium | disodium azodisalicylate | CJ-91B |
|
| Chemical Information |
| Molecular Formula |
C14H10N2O6 |
| CAS Registry Number |
15722-48-2 |
| SMILES |
C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
